Arcturus Therapeutics Holdings Inc ARCT

US Biotechnology

$9.42 ▼ -0.74% ($-0.07)

⬇️ Below Yest. Low 🔥 High Short Interest 🎢 High Beta

Open $9.44

Prev Close $9.49

Day Range $9.15 – $10.04

52W Range $5.50 – $17.96

Market Cap $273.53M

Beta 2.68

EPS (TTM) $-3.31

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2013-05-22
Shares Out.	28,420,000
Website	arcturusrx.com/ ↗
Phone	18009279800
Employees	111
Revenue	$3.0M
Gross Profit	$3.0M
Net Income	-$23.8M
Free Cash Flow	-$72.8M
Total Assets	$224.3M
Total Liabilities	$52.5M
Equity	$171.8M

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Arcturus Therapeutics Holdings Inc is a publicly traded company under the ticker symbol ARCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.